2 terminated. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 1 | 1 | Terminated 1 |
Follow InterMune: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients Interferon Gamma-1b, Rituximab - Non-Hodgkin's Lymphoma | Phase 1 / Phase 2 | Terminated | InterMune | 24 | 2003-03-01 | 2007-11-01 |
| Safety and Efficacy of Inhaled Interferon Gamma-1b in Pulmonary MAC Infection interferon gamma-1b - Lung Infection | Phase 2 | Terminated | InterMune | 100 | 2000-12-01 | 2007-11-01 |
Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Mycobacterium Infections (1) · Mycobacterium avium-intracellulare Infection (1)
interferon gamma-1b (2) · Rituximab (1)
United States (1)
Steven Porter, MD (1) · Williamson Bradford, MD (1)